NCT04490057View on ClinicalTrials.gov

A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

October 24, 2024

Study Completion Date

September 30, 2025

Conditions
Tobacco Use Cessation
Interventions
DRUG

Nicotine patch, nicotine gum, nicotine nasal spray, nicotine inhaler

Participants will be prescribed both long-acting and short-acting nicotine replacement therapy.

DRUG

Varenicline or bupropion

Participants will be prescribed varenicline (Chantix) or bupropion (Wellbutrin).

BEHAVIORAL

Contingency Management

Participants will be financially rewarded for abstinence to tobacco.

Trial Locations (4)

10029

Icahn School of Medicine at Mount Sinai, New York

11203

SUNY Downstate STAR Clinic, Brooklyn

06110

Bridgeport Hospital Infectious Disease Clinic, Bridgeport

06510

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER